Adult Gender Dysphoria with Coronary Disease. Case Report and Literature Review

Rev Colomb Psiquiatr (Engl Ed). 2020 Jul-Sep;49(3):211-215. doi: 10.1016/j.rcp.2018.10.003. Epub 2018 Dec 7.
[Article in English, Spanish]

Abstract

Introduction: Gender dysphoria (GD) refers to a marked incongruity between gender identity and biological sex. GD generates a significant clinical discomfort for at least six months.

Methods: Case report and non-systematic literature review. Case presentation A 56-year-old male-to-female patient, who had a history of coronary disease and a second thromboembolic event after hormone therapy (self-medicated). Once she had received acute management for the cardiovascular disease, she consulted for her GD.

Discussion: GD requires multidisciplinary management. Cross-sex hormonal therapy is considered the main treatment. It has been documented that oral oestrogen preparations may increase the risk of thromboembolic events in patients over the age of 40, especially when they have cardiovascular risk factors.

Conclusions: Comprehensive treatment should be offered to everyone who has GD, to relieve psychological distress, decrease psychiatric comorbidity and improve quality of life. To date, there is little scientific evidence regarding cross-sex hormonal therapy in transgender women over the age of 40; we therefore recommend multidisciplinary, close and rigorous monitoring, in particular when they have cardiovascular risk.

Keywords: Coronary disease; Disforia de género; Drug therapy; Enfermedad coronaria; Gender dysphoria; Personas transgénero; Transgender people; Tratamiento farmacológico.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Coronary Disease / physiopathology*
  • Female
  • Gender Dysphoria*
  • Gonadal Steroid Hormones / administration & dosage
  • Gonadal Steroid Hormones / adverse effects*
  • Heart Disease Risk Factors
  • Humans
  • Male
  • Middle Aged
  • Thromboembolism / chemically induced*

Substances

  • Gonadal Steroid Hormones